Thanks gpo. Important update and color. I suspect that along with me, some others are not listening to the conferences as frequently so posts such as yours are important.
Berger also said that with respect to marketing Ponatinib in Europe, the decision will be made between now and the end of the year. Also per Berger, "we could partner the drug easily based on offers we have in Europe."
Market Data 
Markets 
AI
